Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Pharma Management Consulting Denmark ApS
APS
Active
Advertising protection
CVR 44364182
Stationspladsen 2C, 4180
Sorø
Engineering activities and related technical consultancy
·
NACE 7112
Est. 2023 · 2 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
Engineering activities and related technical consultancy
/
Pharma Management Consulting Denmark ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
1M
2024
1M
2025
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2024
0M
0%
2025
Income statement
DKK thousands
Item
2024
2025
Gross profit
1.400
1.298
Staff expenses
-1.081
-1.042
EBITDA
319
256
Depreciation & amort.
-0
-0
EBIT
319
256
Net financials
-12
-4
Profit before tax
307
252
Tax
70
56
Net profit
237
196
Balance sheet
DKK thousands
Item
2024
2025
Total assets
523
454
Equity
277
243
Long-term debt
0
0
Short-term debt
246
211
Total debt
246
211
Financial ratios
5-year trend
EBITDA margin (of gross profit)
19.7%
This company
2024
2025
Equity ratio
53.6%
This company
38.2%
Market median
+40% vs market
2024
2025
Return on equity
80.7%
This company
18.4%
Market median
+339% vs market
2024
2025
Net profit margin (of gross profit)
15.1%
This company
2024
2025
Asset turnover (of gross profit)
2.86×
This company
2024
2025
Debt / equity
0.87×
This company
0.62×
Market median
+40% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-10-11 – 2024-12-31
View
PDF
More on Pharma Management Consulting Denmark ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
